Jefferies Group's ROIV Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 3.51 M shares of Roivant Sciences Ltd. (ROIV) worth $76.27 M, representing 0.39% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Jefferies Group has maintained this position in ROIV for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 3.51 M shares. Largest reduction occurred in Q3 2024, reducing 132,500 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Roivant Sciences (ROIV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Roivant Sciences (ROIV) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2023 | +62,500 | New Buy | 62,500 | $7.38 |
| Q2 2023 | -12,500 | Reduce 20.00% | 50,000 | $10.08 |
| Q3 2023 | -50,000 | Sold Out | 0 | $0.00 |
| Q2 2024 | +132,500 | New Buy | 132,500 | $10.57 |
| Q3 2024 | -132,500 | Sold Out | 0 | $0.00 |
| Q4 2024 | +40,000 | New Buy | 40,000 | $11.83 |
| Q1 2025 | -40,000 | Sold Out | 0 | $0.00 |
| Q4 2025 | +3.51 M | New Buy | 3.51 M | $21.70 |
Jefferies Group's Roivant Sciences Investment FAQs
Jefferies Group first purchased Roivant Sciences Ltd. (ROIV) in Q1 2023, acquiring 62,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Roivant Sciences Ltd. (ROIV) for 8 quarters since Q1 2023.
Jefferies Group's largest addition to Roivant Sciences Ltd. (ROIV) was in Q4 2025, adding 3,514,833 shares worth $76.27 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 3,514,833 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $76.27 M.
As of the Q4 2025 filing, Roivant Sciences Ltd. (ROIV) represents approximately 0.39% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Roivant Sciences Ltd. (ROIV) was 3,514,833 shares, as reported at the end of Q4 2025.